enGene Therapeutics Inc. is a startup based in Canada, most recent round Series B, 1 tracked investor.
Based in Canada, enGene Therapeutics Inc. is a startup. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
enGene Therapeutics is a clinical-stage biotechnology company developing a novel gene therapy platform for the local delivery of therapeutics. Its lead product candidate, EG-70, is being evaluated in a pivotal study for non-muscle invasive bladder cancer.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.